Overcoming Extracellular Matrix Barriers: Biomaterial-Assisted microRNA Delivery for Fibrous Musculoskeletal Regeneration
aging and disease · 2026
DOI: 10.14336/ad.2026.0343 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift aging and disease, 2026. Verfasst von Ashish Ranjan Sharma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery & Institute for Skeletal Aging, Hallym University-Chuncheon Sacred Heart Hospital, 24252, Gangwon-do, Republic of Ko….
Abstract (Originalsprache)
Fibrous musculoskeletal tissues, including tendons, ligaments, fascia, entheses, and aponeuroses, are strengthened by densely organized collagenous extracellular matrix (ECM) but have limited regenerative capacity. The largely avascular, glycosaminoglycan (GAG)-rich ECM restricts cellular entry, slows matrix turnover, and creates substantial barriers to local therapeutic delivery. Within this setting, a subset of microRNAs (miRNAs) coordinates central aspects of degeneration and repair, including inflammation, angiogenesis, apoptosis, matrix synthesis, and mechanotransduction, making them attractive yet incompletely leveraged therapeutic targets. Clinical translation of miRNA-based approaches, however, is hindered by rapid nuclease degradation, limited penetration into dense collagen networks, electrostatic trapping within the ECM, and inefficient endosomal escape after cellular uptake. Recent advances in biomaterials directly address these challenges by designing carriers that are tailored to the structural and biochemical features of fibrous connective tissues. Approaches such as collagen-binding nanoparticles, mechano- and enzyme-responsive systems, injectable hydrogels with programmable release profiles, and exosome-mimetic vesicles have demonstrated improved miRNA stability, tissue retention, and intracellular delivery in preclinical models. However, the absence of cell-specific targeting ligands, pronounced heterogeneity within and across tendons and ligaments, and pathological matrix stiffening in long-term injuries remain major unresolved issues. The review explores how integrating mechanobiology, RNA engineering, and hierarchical biomaterial design could yield delivery platforms with true spatiotemporal control over miRNA activity, aiming to restore structural integrity in musculoskeletal regions where conventional surgical and pharmacological interventions have repeatedly fallen short.
Autor:innen und Institutionen
- Department of Orthopedic Surgery & Institute for Skeletal Aging, Hallym University-Chuncheon Sacred Heart Hospital, 24252, Gangwon-do, Republic of Korea.
- Department of Biomedical Science & Institute of Bioscience and Biotechnology, Kangwon National University, Chuncheon-si, 24341, Gangwon-do, Republic of Korea.
- Winsløw Unit of Anatomy, Histology and Plastination, Department of Molecular Medicine (IMM) and Danish Institute for Advanced Study (DIAS); University of Southern Denmark (SDU), 5000 Odense, Denmark.
- Institute of Structural Mechanics and Lightweight Design, RWTH Aachen University, 52062 Aachen, Germany.
Zitieren
APA
Sharma, A. R., Lee, Y. H., Sharma, G., Kim, J. G., Kim, J. C., Jahr, H., & Lee, S. S. (2026). Overcoming Extracellular Matrix Barriers: Biomaterial-Assisted microRNA Delivery for Fibrous Musculoskeletal Regeneration. aging and disease. https://doi.org/10.14336/ad.2026.0343
Vancouver
Sharma AR, Lee YH, Sharma G, Kim JG, Kim JC, Jahr H, et al. Overcoming Extracellular Matrix Barriers: Biomaterial-Assisted microRNA Delivery for Fibrous Musculoskeletal Regeneration. aging and disease. 2026. doi:10.14336/ad.2026.0343
BibTeX
@article{Sharma2026,
author = {Sharma, Ashish Ranjan and Lee, Yeon-Hee and Sharma, Garima and Kim, Jae Gyu and Kim, Jin-Chul and Jahr, Holger and Lee, Sang-Soo},
title = {Overcoming Extracellular Matrix Barriers: Biomaterial-Assisted microRNA Delivery for Fibrous Musculoskeletal Regeneration},
journal = {aging and disease},
year = {2026},
doi = {10.14336/ad.2026.0343}
}
EUVIMED